Abstract:Objective: Granulocyte colony-stimulating factor (G-CSF) mobilizes bone marrow mononuclear cells into the peripheral circulation. Stromal cell-derived factor-1 (SDF-1) enhances the homing of progenitor cells mobilized from the bone marrow and augments neovascularization in ischemic tissue. We hypothesize that SDF-1 will boost the pro-angiogenic effect of G-CSF. Methods and results: NIH 3T3 cells retrovirally transduced with SDF-1 alpha gene (NIH 3T3/SDF-1) were used to deliver SDF-1 in vitro and in vivo. Endothelial progenitor cells (EPCs) co-cultured with NIH 3T3/SDF-1 cells using cell culture inserts migrated faster and were less apoptotic compared to those not exposed to SDF-1. NIH 3T3/SDF-1 (106 cells) were injected into the ischemic muscles immediately after resection of the left femoral artery and vein of C57BL/6J mice. G-CSF (25 mu g/kg/day) was injected intraperitioneally daily for 3 days after surgery. Blood perfusion was examined using a laser Doppler perfusion imaging system. The perfusion ratio of ischemic/non-ischemic limb increased to 0.57 +/- 0.03 and 0.50 +/- 0.06 with the treatment of either SDF-1 or G-CSF only, respectively, 3 weeks after surgery, which was significantly higher than the saline-injected control group (0.41 +/- 0.01, P < 0.05). Combined treatment with both SDF-1 and G-CSF resulted in an even better perfusion ratio of 0.69 +/- 0.08 (P < 0.05 versus the single treatment groups). Mice were sacrificed 21 days after surgery. Immunostaining and Western blot assay of the tissue lysates showed that the injected NIH 3T3/SDF-1 survived and expressed SDF-1. CD34(+) cells were detected with immunostaining, capillary density was assessed with alkaline phosphatase staining, and the apoptosis of muscle cells was viewed using an in situ cell death detection kit. More CD34+ cells, increased capillary density, and less apoptotic muscle cells were found in both G-CSF and SDF-1 treated group (P < 0.05 versus other groups). Conclusion: Combination of G-CSF-mediated progenitor cell mobilization and SDF-1-mediated homing of EPCs promotes neovascularization in the ischemic limb and increases the recovery of blood perfusion. 0 2007 European Society of Cardiology. Published by Elsevier B.V.

Role of Stromal Derived Factor-1 and Its Mechanism in Cardiovascular Disease

Stromal cell-derived factor-1 enhances pro-angiogenic effect of granulocyte-colony stimulating factor.

Statin and Stromal Cell-Derived Factor-1 Additively Promote Angiogenesis

Expression of Stromal Cell-Derived Factor-1 after Myocardial Infarction and Its Significance

Current research in relationship of stromal cell derived factor 1 and retinal neovascularization

Stromal Cell-Derived Factor-1 Promotes Bone Marrow-Derived Cells Differentiation to Cardiomyocyte Phenotypes in Vitro.

The role of stromal cell-derived factor 1 on cartilage development and disease

SDF-1-CXCR4 Axis and Tissue Repair after Injury

Stromal Cell-Derived Factor-1 Α Involves in Mobilization of Endothelial Progenitor Cells and Reendothelialization after Artery Injury

SDF-1 Activity on Microvascular Endothelial Cells

SDF 1-alpha Attenuates Myocardial Injury Without Altering the Direct Contribution of Circulating Cells

Effects of SDF-1 α and Its Receptor on Regulation of Hematopoiesis

CKLF1 in cardiovascular and cerebrovascular diseases

The Role of Stromal Cell Derived Factor-1 and Its Receptor CXCR4 in the Migration of Adult Stem Cells

Stromal Cell-Derived Factor-1 Expression in Atherosclerotic Lesions Induced by Low Shear Stress

The Expression and Its Meaning of the Stromal Cell - derived Factor- 1α and Its Receptor in Myocardal Changes of Rats with Diabetes

The Effects of Chemokine SDF-1 on ADSCs Differentiation into VECs

Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism.

Stromal Cell-Derived Factor-1 Exerts Opposing Roles Through CXCR4 and CXCR7 in Angiotensin II-induced Adventitial Remodeling.

SDF-1-CXCR4 Axis and Stem Cell Therapy of the Ischemic Heart Disease

Role of stromal cell-derived factor-1α in patients with acute ST-elevation myocardial infarction